Development of polypoidal lesions in age-related macular degeneration

Eye

Volumn 25, Issue 4, 2011, Pages 481-488

  Tsujikawa, A ^a   Ojima, Y ^a   Yamashiro, K ^a   Ooto, S ^a   Tamura, H ^a   Nakata, I ^a   Yoshimura, N ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

age related macular degeneration; indocyanine green angiography; polypoidal choroidal vasculopathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MEDICAL PHOTOGRAPHY; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION;

EID: 79954531315     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.232     Document Type: Article

References (42)

1. Kleiner RC, Brucker AJ, Johnston RL. The posterior uveal bleeding syndrome. Retina 1990; 10: 9-17. (Pubitemid 20201880)
2. Stern RM, Zakov ZN, Zegarra H, Gutman FA. Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 1985; 100: 560-569. (Pubitemid 16206988)
3. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10: 1-8. (Pubitemid 20201879)
4. Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 1999; 117: 1035-1042. (Pubitemid 29372936)
5. Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 2002; 133: 639-648. (Pubitemid 34462012)
6. Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA. Polypoidal choroidal vasculopathy Surv Ophthalmol 2004; 49: 25-37. (Pubitemid 38056622)
7. Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121: 1392-1396. (Pubitemid 37243739)
8. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy Retina 1995; 15:100-110.
9. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 1997; 115: 478-485. (Pubitemid 27172703)
10. Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117: 1503-1510. (Pubitemid 29536478)
11. Moorthy RS, Lyon AT, Rabb MF, Spaide RF, Yannuzzi LA, Jampol LM. Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 1998; 105: 1380-1385. (Pubitemid 28509753)
12. Lee SY, Kim JG, Joe SG, Chung H, Yoon YH. The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy Korean J Ophthalmol 2008; 22: 92-99.
13. Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M et al. Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 2008; 92: 70-73.
14. Lai TY, Chan WM, Liu DT, Luk FO, Lam DS. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Br J Ophthalmol 2008; 92: 661-666. (Pubitemid 351684177)
15. Tsujikawa A, Ooto S, Yamashiro K, Tamura H, Otani A, Yoshimura N. Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab. Jpn J Ophthalmol 2010; 54: 310-319.
16. Kokame GT, Yeung L, Lai JC. Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br J Ophthalmol 2010; 94: 297-301.
17. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-1431. (Pubitemid 44511557)
18. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RYet al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-1444. (Pubitemid 44511558)
19. Cho M, Barbazetto IA, Freund KB. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 2009; 148: 70-78.
20. Stangos AN, Gandhi JS, Nair-Sahni J, Heimann H, Pournaras CJ, Harding SP. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab. Am J Ophthalmol 2010; 150: 666-673.
21. Tateiwa H, Kuroiwa S, Gaun S, Arai J, Yoshimura N. Polypoidal choroidal vasculopathy with large vascular network. Graefes Arch Clin Exp Ophthalmol 2002; 240: 354-361 (Pubitemid 36075609)
22. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for Evaluation and Treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991; 109: 1242-1257.
23. Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA. Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992; 12: 191-223.
24. Yuzawa M, Kawamura A, Matsui M. Clinical evaluation of indocyanine green video-angiography in the diagnosis of choroidal neovascular membrane associated with age-related macular degeneration. Eur J Ophthalmol 1992; 2: 115-121.
25. Lafaut BA, Aisenbrey S, Van den Broecke C, Bartz-Schmidt KU, Heimann K. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20: 650-654. (Pubitemid 32427983)
26. Terasaki H, Miyake Y Suzuki T, Nakamura M, Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol 2002; 86: 321-327. (Pubitemid 34206348)
27. Gass JDM. Update clininicopathologic classification of subretinal neovascularization. Am Soc Retina Special, Online Journal Vol. 3 2004.
28. Yoneya S, Saito T, Komatsu Y, Koyama I, Takahashi K, Duvoll-Young J. Binding properties of indocyanine green in human blood. Invest Ophthalmol Vis Sci 1998; 39: 1286-1290. (Pubitemid 28247368)
29. Guyer DR, Puliafito CA, Mones JM, Friedman E, Chang W, Verdooner SR. Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology 1992; 99: 287-291.
30. Imaizumi H, Takeda M. [Knobby-like choroidal neovascularization accompanied with retinal pigment epithelial detachment]. Nippon Ganka Gakkai Zasshi 1999; 103: 527-537. (Pubitemid 29359663)
31. Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy: an angiographic discussion. Eye 2010; 24: 483-490.
32. Otani A, Sasahara M, Yodoi Y Aikawa H, Tamura H, Tsujikawa A et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 2007; 144: 7-14.
33. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144: 15-22.
34. Sakurada Y, Kubota T, Imasawa M, Tsumura T, Mabuchi F, Tanabe N et al. Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy Retina 2009; 29: 1522-1526.
35. Mori K, Horie-Inoue K, Gehlbach PL, Takita H, Kabasawa S, Kawasaki I et al. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology 2010; 117: 928-938.
36. Lee KY, Vithana EN, Mathur R, Yong VH, Yeo IY, Thalamuthu A et al. Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy Invest Ophthalmol Vis Sci 2008; 49: 2613-2619.
37. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 2007; 144: 608-612.
38. Gotoh N, Nakanishi H, Hayashi H, Yamada R, Otani A, Tsujikawa A et al. ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy Am J Ophthalmol 2009; 147: 1037-1041.
39. Lima LH, Schubert C, Ferrara DC, Merriam JE, Imamura Y, Freund KB et al. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy Ophthalmology 2010; 117: 1567-1570.
40. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy Invest Ophthalmol Vis Sci 2008; 49: 1101-1105.
41. Okubo A, Arimura N, Abematsu N, Sakamoto T Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes. Acta Ophthalmol 2010; 88: e107-e114.
42. Okubo A, Hirakawa M, Ito M, Sameshima M, Sakamoto T Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration. Graefes Arch Clin Exp Ophthalmol 2008; 246: 491-499. (Pubitemid 351447961)